Towards a reference methodology for bacteriophage susceptibility testing - position paper of the EUCAST Phage Susceptibility Testing Subcommittee.
Saved in:
| Title: | Towards a reference methodology for bacteriophage susceptibility testing - position paper of the EUCAST Phage Susceptibility Testing Subcommittee. |
|---|---|
| Authors: | Classen AY; Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, University of Cologne, Cologne, Germany; German Centre for Infection Research (DZIF), Braunschweig, Germany; Institute for Medical Microbiology, Immunology and Hygiene, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; ESGNTA - ESCMID Study Group for Nontraditional Antibacterials, Basel, Switzerland. Electronic address: annika.classen@uk-koeln.de., Clokie MRJ; Becky Meyer Centre for Phage Research, Division of Microbiology and Infection, School of Biological and Biomedical Sciences, University of Leicester, Leicester, UK., Giske CG; ESGNTA - ESCMID Study Group for Nontraditional Antibacterials, Basel, Switzerland; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden., Paz RN; ESGNTA - ESCMID Study Group for Nontraditional Antibacterials, Basel, Switzerland; Hadassah-Hebrew University Medical Center, and The Faculty of Medicine, the Hebrew University, Jerusalem, Israel., Pirnay JP; ESGNTA - ESCMID Study Group for Nontraditional Antibacterials, Basel, Switzerland; Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, Brussels, Belgium., Resch G; ESGNTA - ESCMID Study Group for Nontraditional Antibacterials, Basel, Switzerland; Laboratory of Bacteriophages and Phage Therapy, Center for Research and Innovation in Clinical Pharmaceutical Science (CRISP), Lausanne University Hospital (CHUV), Lausanne, Switzerland., Laurent F; ESGNTA - ESCMID Study Group for Nontraditional Antibacterials, Basel, Switzerland; Therapeutic Phage Laboratory, Institute for Infectious Agents, Hospices Civils de Lyon, Lyon, France; Team 'Staphylococcal pathogenesis', Centre International de Recherche en Infectiologie (CIRI), INSERM U1111 - CNRS UMR5308 - ENS Lyon - Lyon 1 University, Code 2025, Lyon, France. |
| Corporate Authors: | EUCAST Phage Susceptibility Testing Subcommittee |
| Source: | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2026 Jun 13. Date of Electronic Publication: 2026 Jun 13. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 9516420 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1469-0691 (Electronic) Linking ISSN: 1198743X NLM ISO Abbreviation: Clin Microbiol Infect Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42288126 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Towards a reference methodology for bacteriophage susceptibility testing - position paper of the EUCAST Phage Susceptibility Testing Subcommittee. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Classen+AY%22">Classen AY</searchLink>; Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, University of Cologne, Cologne, Germany; German Centre for Infection Research (DZIF), Braunschweig, Germany; Institute for Medical Microbiology, Immunology and Hygiene, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; ESGNTA - ESCMID Study Group for Nontraditional Antibacterials, Basel, Switzerland. Electronic address: annika.classen@uk-koeln.de.<br /><searchLink fieldCode="AU" term="%22Clokie+MRJ%22">Clokie MRJ</searchLink>; Becky Meyer Centre for Phage Research, Division of Microbiology and Infection, School of Biological and Biomedical Sciences, University of Leicester, Leicester, UK.<br /><searchLink fieldCode="AU" term="%22Giske+CG%22">Giske CG</searchLink>; ESGNTA - ESCMID Study Group for Nontraditional Antibacterials, Basel, Switzerland; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Paz+RN%22">Paz RN</searchLink>; ESGNTA - ESCMID Study Group for Nontraditional Antibacterials, Basel, Switzerland; Hadassah-Hebrew University Medical Center, and The Faculty of Medicine, the Hebrew University, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Pirnay+JP%22">Pirnay JP</searchLink>; ESGNTA - ESCMID Study Group for Nontraditional Antibacterials, Basel, Switzerland; Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Resch+G%22">Resch G</searchLink>; ESGNTA - ESCMID Study Group for Nontraditional Antibacterials, Basel, Switzerland; Laboratory of Bacteriophages and Phage Therapy, Center for Research and Innovation in Clinical Pharmaceutical Science (CRISP), Lausanne University Hospital (CHUV), Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Laurent+F%22">Laurent F</searchLink>; ESGNTA - ESCMID Study Group for Nontraditional Antibacterials, Basel, Switzerland; Therapeutic Phage Laboratory, Institute for Infectious Agents, Hospices Civils de Lyon, Lyon, France; Team 'Staphylococcal pathogenesis', Centre International de Recherche en Infectiologie (CIRI), INSERM U1111 - CNRS UMR5308 - ENS Lyon - Lyon 1 University, Code 2025, Lyon, France. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22EUCAST+Phage+Susceptibility+Testing+Subcommittee%22">EUCAST Phage Susceptibility Testing Subcommittee</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229516420%22">Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</searchLink> [Clin Microbiol Infect] 2026 Jun 13. <i>Date of Electronic Publication: </i>2026 Jun 13. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9516420 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1469-0691 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221198743X%22">1198743X </searchLink><i>NLM ISO Abbreviation: </i>Clin Microbiol Infect <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42288126 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.cmi.2026.06.005 Languages: – Code: eng Text: English Titles: – TitleFull: Towards a reference methodology for bacteriophage susceptibility testing - position paper of the EUCAST Phage Susceptibility Testing Subcommittee. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Classen AY – PersonEntity: Name: NameFull: Clokie MRJ – PersonEntity: Name: NameFull: Giske CG – PersonEntity: Name: NameFull: Paz RN – PersonEntity: Name: NameFull: Pirnay JP – PersonEntity: Name: NameFull: Resch G – PersonEntity: Name: NameFull: Laurent F IsPartOfRelationships: – BibEntity: Dates: – D: 13 M: 06 Text: 2026 Jun 13 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1469-0691 Titles: – TitleFull: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases Type: main |
| ResultId | 1 |